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       Synthesis of Hexapeptides Having Cysteines 
                at N- and C-Terminals 
                           Sho TAKAHASHI
                             ReceivedAugust30,1988
   In an attempt to evaluate a propensity of turn or  fl-structure formation of an amino acid residue, 
several hexapeptides having a sequence of R1-CysXABYCys-R2 ( 1=H or Ac, R2=OH or NHCH3) 
were synthesized with a solution method. Residues A and B were selected to form a turn (Gly or Pro), 
X and Y to form a fl-structure (Gly, Val, Lys, Glu). 
   KEY WORDS: Peptide synthesis/ Solution method/ Hexapeptides/ 
                 Cysteine-cystine/ Disulfide/ 
f-Structure is one of the two ordered secondary structures essential in proteins. 
The other structure, a-helix, has been studied exhaustively, both experimentally and 
theoretically. The Zimm-Bragg's parameters, s and a, which determine the stabil-
ity of an a-helix, have been determined for almost all twenty amino acids found in 
protein (for the most recent result, see Ref. 1). On the contrary, ft-structure has 
been studied only scarcely. The reason was, in most cases experiments carried out, 
an inevitable presence of intermolecular interactions in ft-structure, which was due 
to characteristic long-range interaction in ft-structure and not appeared in the struc-
ture of a-helix. Only few examples of synthetic polypeptides assuming exclusively 
intramolecular ft-structures have been reported.2'3) 
   Very recently, Scheraga, Konishi and coworkers proposed a new model system 
which was consisted of a small peptide and would enable a quantitative evaluation 
of a tendency of an amino acid residue to form ft-structure. The method is based 
on disulfide bond formation between two cysteine residues located at the N- and 
C-terminal of a ft-forming peptide. Coupled with a new theory of a ft-coil transi-
tion,41 which is somewhat similar to Zimm-Bragg's treatment of a-helix, it will be 
possible to analyze the thermodynamic stabilities of ft-structures as in the same level 
as for a-helices. In this report, we will describe the synthesis of several hexapeptides 
containing cysteines at the N- and C-terminal, which are necessary for a study in 
these lines. 
                      RESULTS AND DISCUSSION 
   Seven hexapeptides 8, 14, 21, 22, 31, 38, and 45 were synthesized by conven-
tional procedures as outlined in Fig. 1. The design of these compounds was as fol-
lows: (1) In peptides 21, 22, 31, 38, and 45, proline and glycine were selected 
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 Cys Gly (I) (I)) G!y Cys 
                     {Boc—OSu Boc-------------OHBocXcm Acm Boc------------OSu Boc---------------------------'X (3, 10.15) 
                                                                             Acm 
             Boc------------------------------------/X (16) 
                                   Acm 
Boc—LOSu Boc---------------------------------------pcm                                                                    X (6, 11, 17) 
AcmAcm 
Boc---------------------------------------------------------12 (7, 13, 18) 
     Boc---------------------------------------------------------------X (6 )
Boc /--------/X (19) 
               y / I I I I VX (14,20,21, 22) 
                                           Fig. 1A 
                          Fig. 1A. Synthesis of 14, 20, 21, and 22. 
                               X=OH (14, 21, 22) ; OBz1 (others) 
                              Y=H (14, 22); Ac (20, 21) 
(I)=Gly (3-14) ; Pro (16-22) 
(II)=Gly (3-8, 15-22) ; Pro (10-14) 
                   Cys (111) Pro GIy (IV) Cys 
R1 HCI Acm 
                                  Boc OSu H OH Boc OH H NHMe
R1 Acm 
                            BocOH BocNHMe (24,32, 39) 
R2 Acm 
Boc OH BocNHMe (26, 33, 40) 
       AcmR2Acm 
Boc Boc OH BocNHMe (27, 34, 42) 
       BocAcm~Acm                                                                   NHMe(28, 35) 
       Ac ~~--1.1 Acm                                                                   NHMe(29, 36. 44) 
      R21 
         Ac
INHMe(30, 37 ) 
             AcI I I I NHMe(31, 38, 45) 
Fig. '1B 
                          Fig. 1B. Synthesisof 31, 38, and 45. 
R1=Z (24-30 ; OBz1 (32-37) 
R2=OBz1 (27-30; Z (34-37) 
(III))=Glu (27-31) ; Lys (34-38) ; Val (42-45) 
(IV)=Lys (24-31) ; Glu (32-38); (39-45) 
   as the third and fourth residues, respectively, which would give the most probable 
   sequence for a Q-turn. (2) Peptide 14 was designed to see the effect of the se-
   quence reversed as G1y3-Pro4. (3) In peptide 8, a neutral sequence G1y3-G1y4 was 
   introduced in the position of peptide turn. (4) Four peptides were synthesized to 
   see the effect of electric charges at terminals (peptides 21 and 22) or at the penul-
   timate positions (peptides 31 and 38). (5) In peptide 45, valine was selected for 
   the positions 2 and 5, the amino acid had been assumed the highest propensity for 
ft-structure. 
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          Peptide coupling was carried out in most cases with dicyclohexylcarbodiimide 
      in the presence of 1.5 eq. of 1-hydroxybenzotriazole. Disulfide bonds formation in 
      hexapeptide was achieved by an oxidation with iodine. The products were charac-
      terized by elemental analysis, amino acid analysis and 1H-NMR. The determination 
      of thermodynamic constants of disulfide-thiols equilibrium for each hexapeptide will 
      be published elsewhere.13) 
                                 EXPERIMENTAL 
           All amino acids are of L-configuration except glycine. Melting points were measured on a micro 
        hotplate and described without correction. Proton magnetic resonance spectra were taken with a 
       JEOL FX100 (100 MHz) or a JEOL GX400 (400 MHz) spectometer as solutions in dimethyl-d6 sul-
        foxide, and the chemical shifts are reported in ppm from internal tetramethylsilane. Chemical shifts 
        without any notation mean the center of multiplets. Amino acid analysis of acid hydrolyzates (6N 
HC1, 110°C, 24 h, unless otherwise noted) were carried out on a JASCO amino acid analyzer with 
NaBH4-ninhydrin system5). Solvents for TLC had the following ratio of chloroform: methanol:acetic 
       acid, (I) 95:5:1, (II) 90:10:1, (III) 80:20:1, (IV) 100:14:1, (V) 60:40:1. Merck HPTLC plates 
       were used with these solvents. Diisopropylethylamine (Sigma) was distilled over ninhydrin after treat-
       ment with KOH pellets. 
           Elemental analyses were carried at the Facility of Elemental Analysis, Institute for Chemical Re-
        search, Kyoto University. 
       BOC-Cys(Acm)-OCH,Ph(p-NO2-), (1). The ester was synthesized from the cesium salt of BOC-
        Cys(Acm)-OH, which was prepared from H-Cys(Acm)-0H6) by the method of Itoh et al.7), and p-nitro-
        benzyl bromide according to the method of Wang et al.8)) Yield, 68%. After recrystallization from 
        ethanolether, the compound had m.p. 110-112°C. Anal. Found: C, 50.58; H, 5.80; N, 9.94%. 
       Calcd for C18H2507N3S: C, 50.58; H, 5.90; N, 9.63%. TLC: Rf(I)=0.66. 
HCI-H-Cys(Acm)-OCH2Ph(p-NO,-), (2). Removal of Boc group of compound 1 was carried out by the 
       addition of 5 ml of HC1-saturated ethyl acetate to the solution of 2.14 g of 1 in 5 ml of ethyl acetate. 
        The mixture was kept at room temperature for 1 h. The hydrochloride was filtered and washed with 
        ether. Yield, quantitative. m.p. 157-159°C (decomposition). Anal. Found: C, 42.84; H, 4.93; N, 
        11.63%. Calcd for C13H1805N3C1S: C, 42.91; H, 4.99; N, 11.55%. TLC: Rf(I)=0.17. 
Boc-GlyGlyCys(Acm)-OCH2Ph(p-NO2-), (3 . p-Nitrophenylester of Boc-GlyGly-OH (1.59 g, 4.5 mmol) 
       and 2 (1.64 g, 4.5 mmol) were treated with DIEA (1.74 ml, 9.9 mmol) in 10 ml of dry DMF at room 
        temperature overnight. The reaction mixture was evaporated in vacuo to leave the residue, which was 
        dissolved in ethyl acetate. The solution was washed successively with 10% aq. citric acid, 3% aq. so-
        dium hydrogen carbonate, water, and finally with saturated aq. sodium chloride, dried over sodium 
        sulfate, then evaporated to afford 3, which was crystallized from ethanol-ether or ethyl acetate. Yield, 
        82%. m.p. 130-133°C. Anal. Found: C, 48.82; H, 5.71; N, 13.00%. Calcd for C22H3109N6S: C, 
       48.79; H, 5.77; N, 12.93%. TLC: Rf(II)"=0.47. NMR: 1.36(s, 9H: Boc), 1.82(s, 3H: Ac), 2.94(2H: 
(Cys)Cf-2H), 3.56(2H: (Glyl)Ca-2H), 3.76(2H: (Gly2) Ca - 2H), 4.2(2H: (Acm)CH2), 4.6(1H: 
(Cys)Ca-H), 5.26(s, 2H: CH2 of p-nitrobenzyl), 6.92(t, 1H: (Gly1) NH) , 7.6-8.2(4H: p-nitrophenyl), 
       8.00(t, 1H: (G1y2)NH), 8.42(d, 1H: (Cys)NH), 8.48(t, 1H: (Acm)NH). 
HCI-H-GlyGlyCys(Acm)-CH2Ph(p-NO2), (4 . Boc-tripeptide ester 3, 3.72 g, was dissolved in 10 ml of 
        dichloromethane and treated with 5 ml of TFA at room temperature for 1.5 h. The solution was evapo-
        rated and deblocking was completed with HC1/ethyl acetate. Yield, quantitative. Found: C, 39.36; 
       H, 4.68; N, 12.46%. Calcd for C,,H2407N5SC1.1/2 CF3CO2H-H2O: C, 39.06; H, 4.83; N, 12.66%. 
       Boc-GlyGly-OSu, (5). The compound was synthesized from Boc-GlyGly-OH and HOSu with DCC in 
        DMF. The DCC reaction was carried out at -12°C for first two hours, then at 0°C overnight. Yield 
        Abbreviations used: Acm, S-acetamidomethyl; DCC, dicyclohexylcarbodiimide; DIEA, N,N-di-
       isopropylethylamine ; DMF, N,N-dimethylformamide ; HOBT, hydroxybenzotriazole ; TFA, tri-
        fluoroacetic acid; TLC, thin-layer chromatography. 
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        of 5, 79%; m.p. 163-166°C (recrystallized from ethyl acetate). Found: C, 47.41; H, 5.58; N, 12.81%. 
        Calcd for  C13H19O7N3: C, 47.41; H, 5.82; N, 12.76%. 
       Boc-GlyGlyGlyGlyCys(Acm)-CH2Ph(p-NO2-), (6). Hydrochloride 4, 3.4 g (6.15 mmol), was reacted with 
       2.02 g (6.15 mmol) of 5 and DIEA (1.18 ml, 6.77 mmol) in 20 ml of DMF at room temperature for 15 h. 
        Additional 0.2 ml of DIEA and 0.16 g of glycine were added to the reaction mixture, and the whole 
        mixture was kept at room temperature for 24 h, then evaporated. The residue eas dissolved in 1-butanol 
        and the solution was washed with acid and alkali. Evaporation of the solvent gave an oil, which was 
        extracted with ethanol to remove some solids. Ethanol solution afforded 6 upon the addition of ether. 
       Yield, 3.6 g (89%). TLC: Rf(III) 0.66. NMR: 1.38(s,9H: Boc), 1.84(s, 3H: Ac), 2.8-3.1(2H: 
(Cys)Cf-2H), 3.58(d, 2H: (Gly1)Ca-2H), 3.7-3.8(6H: 3(Gly)Ca-2H), 4.2-4.3(2H: (Acm) CH2), 
4.62(1H: (Cys)Ca-H), 5.29(s, 2H: CH2 of p-nitrophenyl), 7.01(t, 1H: (Gly1)NH), 7.7-8.2(4H: 
        p-nitrophenyl), four triplets for (Gly) NH at 8.04, 8.16, 8.18, and 8.55; 8.48(d, 1H: (Cys)NH). 
        Boc-Cys(Acm)GlyGlyGlyGlyCys(Acm)-CH2Ph(p-NO2-), (7). Boc-pentapeptide6, 3 g, was treated first with 
       50% TFA in dichloromethane then with 3M HC1 in ethyl acetate. Yield of HC1.H-GlyGlyGlyGly-
        Cys(Acm)-CH2Ph(p-NO2-) was 2.8 g (quantitative). This hydrochloride was reacted with 1.8 g (4.6 
        mmol) of Boc-Cys(Acm)-OSu6) and 0.87 ml (5 mmol) of DIEA in 20 ml of dry DMF at room tem-
        perature for 15 h. Additional 0.3 ml of DIEA was added to the reaction mixture, the whole mixture 
        was stood for 6 h, and evaporated. The residue was dissolved in 1-butanol and the solution was 
        washed successively with KCI-saturated aq. K2CO3i saturated aq. NaCl. The product was cry-
        stallized from 1-butanol-saturated water. Yield, 2.74 g (69%); mp. 194-195°C (dec.). Found: C, 
        44.52; H, 5.65; N, 14.47%. Calcd for C32H47O13NgS2.2H2O: C, 44.38; H, 5.94; N, 14.56%. NMR: 
       1.38 (s, 9H: Boc), 1.836 (s, 3H: (Acm)CH3), 1.844 (s, 3H: (Acm)CH3), 2.88 and 3.04 (a pair of quartet, 
       2H: (Cys6)C9-2H), 2.67 and 2.91 (a pair of quartet, 2H: (Cysl)Cj-2H), 3.7-3.8 (8H: 4(Gly)Ca-
       2H), 4.18 (q, 1H: (Cys)Ca-H), 4.25 (4H: 2(Acm)CH2), 4.62 (1H: (Cys)Ca-H), 5.30 (s, 2H: CH2 
        of p-nitrobenzyl), 7.02 (d, 1H: (Cysl)NH), 7.66-8.24 (4H: p-nitrophenyl), 8.1-8.2 and 8.4-8.6 (seven 
        NH protons). 
       H-Cys(Acm)GlyGlyGlyGlyCys(Acm)-OH, (8). Compound 7, 0.83 g (1 mmol), was dissolved in 12 ml of 
        methanol and saponified with 1.1 ml of 1 M NaOH. After 1 h at room temperature, the solution 
        was neutralized with dil. HC1 and evaporated to dryness. The residue was redissolved in water 
        and p-nitrobenzyl alcohol was removed by extraction with ether. The aqueous layer was lyophilized 
        to give 0.7 g of crude free acid. This material was dissolved in chloroform-methanol (80:20) and 
        chromatographed on SiO2. Elution with chloroform-methanol (60:40) afforded Boc-Cys(Acm)Gly4-
       Cys(Acm)-OH which gave a single spot on TLC, Rf(V), 0.45. Yield, 0.6 g. This Boc-hexapeptide 
        acid was treated with 5 ml of 50% TFA in dichloromethane at room temperature for 3 h. The re-
        sidue which was obtained by evaporation of the mixture was dissolved in ethyl acetate and treated with 
       3 M HC1 in ethyl acetate. Hydrochloride of 8 was filtered and washed with ether. Yield, 0.56 g. The 
       compound was purified by chromatography on a BioRad AG50W-X2 column under the conditions of 
Schroeder9>. Amino acid analysis of the air-oxidized hydrolyzate as described6) gave the value of 
Gly :Cys2=1 :0.126. Under the same conditions, both of Boc-GlyGlyCys(Acm)-OBz1 and Boc-GlyGly-
        Cys(Acm)-OCH/Ph(p-nitro-) gave the amount of Cys2 between 0.116 and 0.118. Therefore, when we 
        adopted the value 0.117 as the reference, the amino acid composition of 8 was obtained as Gly:Cys= 
       4:2.14. NMR: 1.83 (s, 3H: (Acm)CH3), 1.85 (s, 3H: (Acm)CH3), 2.7-3.0 (4H: 2(Cys)Cj-2H), 3.6-
       3.9 (9H: 4(Gly)Ca-2H), (Cys)Ca-H), 4.2-4.3 (5H: 2(Acm)CH2i (Cys)Ca-H), 7.82 (d, 1H: (Cys6)NH), 
       six triplets (1H, each) for four (Gly)NH and two (Acm)NH at 8.18, 8.23, 8.32, 8.49, 8.72, and 8.89. 
Boc-GlyCys(Acm)-OBzl, (9). Boc-Cys(Acm)-OBzl10>, 3.82 g (10 mmol), was converted to HCl•H-
        Cys(Acm)-OBzl with the same procedure as for the preparation of 2. The hydrochloride was 
       neutralized with 2.1 ml of DIEA in 50 ml of DMF and reacted with 1.74 g (10 mmol) of Boc-Gly-
       OH, 2.1 g of DCC (10 mmol), and 1.62 g (12 mol) of HOBT at 0°C for 15 h. Product 9 was 
        recrystallized from ethyl acetate-ether. Yield, 3.7 g (84%); m.p. 92-93°C. Found: C, 54.54; H, 
       6.48; N, 9.52%. Calcd for C20H29O6N3S: C, 54.66; H, 6.65, N, 9.56%. NMR: 1.36 (s, 9H: Boc), 
       1.81 (s, 3H: (Acm) CH3), 2.92 (2H: (Cys)C,B-2H), 3.56 (2H: (Gly)Ca-2H), 4.2 (2H: (Acm) CH2), 4.56 
       (1H: (Cys)Ca-H), 5.10 (s, 2H: (Bzl)CH2), 6.92 (t, 1H: (Gly)NH), 7.3 (511: Ph), 8.28 (d, 1H: 
       (Cys)NH), 8.46 (t, 1H: (Acm)NH). 
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Boc-Pro-GlyCys(Acm)-OBzl, (10). To a solution of 9 (4.66 g, 10.6 mmol) in 40 ml of ethyl acetate 
was added 10 ml of HC1-saturated ethyl acetate. The mixture was stood at room temperature for 
2 h, then evaporated. The solid was washed thoroughly with ether to afford 4.0 g of HC1•11-Gly-
Cys(Acm)-OBz1. Yield, quantitative. To a suspension of this hydrochloride (4.0 g), in 20 ml of DMF, 
2.1 ml of DIEA (1.2 eq)., 2.25 g of Boc-Pro-OH (1.05 eq.), 2.05 g (1.5 eq.) of HOBT, and 2.17 g 
(1.05 eq.) of DCC in 2 ml of ethyl acetate were added in this order at 0°C. The reaction mixture 
was kept at 2-3°C overnight, filtered, and evaporated. The residue was dissolved in ethyl acetate and 
washed with acid and alkali. Compound 10 was recrystallized from ethyl acetate-ether; m.p. 123°C. 
Yield, 4.5 g (84%). Found: C, 55.94; H, 6.63; N, 10.44%. Calcd for C25H36O7N4S: C, 55.96; H, 
6.76; N, 10.44%. NMR: The spectrum was somewhat complex due to the presence of a cis-trans 
isomerism about the prolyl peptide bond. 1.35 and 1.39 (two singlets with intensity ratio=57:43, 
respectively, total 9H: Boc), 1.82 (s, 3H: (Acm)CH3), 1.7-2.1 (4H: (Pro)C/G, r-4H), 2.8-3.0 (2H: 
(Cys)Cf-2H), 3.2-3.4 (2H: (Pro)C8-2H), 3.65-3.9 (2H: (Gly)Ca-2H), 4.1 (2H: (Acm)CH2), 4.2 
(11I: (Pro)Ca-H), 4.5 (1H: (Cys)Ca-H), 5.14 (s, 2H: (Bz1)CH2), 7.37 (5H: Ph), 8.06 and 8.16 (two 
triplets with intensity ratio about 6:4, total 1H: (Gly)NH), 8.28 and 8.43 (two doublets with intensity 
ratio about 6:4, total 1H: (Cys)NH), 8.52 (t, 1H: (Acm)NH). 
Boc-GlyGlyProGlyCys(Acm)-OBzl, (11). Compound 10 (4 g, 7.5 mmol) was dissolved in 50 ml of hot 
ethyl acetate. The solution was cooled with an ice-bath and 10 ml of HC1-saturated ethyl acetate 
was added. The hydrochloride separated as an oil solidified on standing at room temperature for 
3 h. This hydrochloride was collected and dissolved in 5 ml of DMF and neutralized with 1.55 ml of 
DIEA at 0°C. To the solution were added 1.52g (1.5 eq.) of HOBT, 1.74g (7.5 mmol) of Boc-Gly-
Gly-OH, and 1.55 g of DCC in 4 ml of DMF in this sequence at 0°C. The reaction mixture was 
kept at 2-3°C for 24 h, filtered and evaporated. The residue dissolved in 1-butanol was worked up 
as described above. The crude products were chromatographed on SiO2 with chloroform-methanol 
(95:5) and pentapeptide 11 was recrystallized from methanol-ether; m.p. 105-107°C (dec.). Found: 
C, 52.88; H, 6.46; N, 12.58%. Calcd for: C29H42O9N6S•1/2 H2O: C, 52.80; H, 6.57; N, 12.74%. 
TLC: Rf (I) 0.31. 
HC1.H-GlyGlyProGlyCys(Acm)-OBz1, (12). TFA (5 ml) was added to a suspension of 3.5 g (5.4 mmol) 
of compound 11 in 8 ml of dichloromethane and 1.25 ml of anisole at 0°C. The mixture was kept 
at room temperature for 2 h. After concentration to a smaller volume, the residue was dissolved in 
small amount of ethyl acetate and treated with 3M HC1-ethyl acetate at room temperature for 0.5 h. 
Hydrochloride 12 was filtered and washed with ether. Yield, quantitative. NMR: 1.6-2.2 (4H 
except Ac: (Pro)Cj, T-4H), 1.82 (s, 3H: Ac), 2.8-3.0 (2H: (Cys)C19-2H), 3.3-3.9 (6H), 3.9-4.1 (2H), 
4.19 (d, 2H: (Acm)CH2), 4.4-4.6 (2H), 5.08 (s, 211: (Bz1)CH2), 7.33 (5H: Ph), 8.0-8.6 (4H: NH); 
ammonium protons appeared as a very broad signal around 5.4 ppm. 
Boc-Cys(Acm)GlyGlyProGlyCys(Acm)-OBzl, (13). Compound 12, obtained from 3.5 g (5.4 mmol) of 11, 
was dissolved in 15 ml of DMF and neutralized with 1.13 ml (1.2 eq.) of DIEA with cooling in an 
ice-bath. The coupling with Boc-Cys(Acm)-OH (1.73 g, 1.1 eq.) was carried out with 1.16 g (1.05 
(eq.) of DCC and 1.1 g (1.5 eq.) of HOBT at -13°C for initial 1 h, then at 0°C overnight. Because 
the presence of the starting pentapeptide was shown on a TLC plate, additional amounts of reagents 
(0.7 ml of DIEA, 0.25 g of Boc-Cys(Acm)-OH, and 0.25 g of DCC) were added and the mixture was 
kept at 2-3°C for 2 days, and finally at room temperature for 24 h. Although the TLC spot, Rf of 
which was same as that for 12, still persisted at this stage, the reaction mixture was filtered, evaporated 
to give the residue which was dissolved in 1-butanol, and worked up as previously described. The 
product was chromatographed on SiO2i the desired product was eluted at the concentration of me-
thanol 5 to 7% in chloroform. Yield of the powder from methanol-chloroform having m.p. 83-85°C 
(dec. at about 100°C) was 2.67 g (60%). Found: C, 50.63; H, 6.35; N, 13.20%. Calcd for 
C35H52OnN8S2 1/2 H2O: C, 50.40; H, 6.41; N, 13.44%. NMR: 1.38 (s, 911: Boc), 1.82 (s, 3H: Ac), 
1.85 (s, 3H: Ac), 1.7-2.0 (4H: (Pro)Cf, r-411), 2.6-3.0 (4H: 2 (Cys) Cg-2H), 3.4-3.6 (211: (Pro)C8- 
211), 3.6-4.3 (6H: 3(Gly)Ca-2H), 4.2 (t, 1H: (Pro)Ca-H), 4.6 (211: 2(Cys) Ca-H), 5.14 (s, 2H: (Bz1)-
CH2), 7.01 (d, 111: (Cysl) NH), 7.49 (5H: Ph), 7.94, 8.11, and 8.21 (three triplets, each 1H: 3(Gly)-
NH), 8.26 (d, 111: (Cys6)NH), 8.50 (t, 211: 2(Acm)NH). 
S ---------- S 
H-CysGlyGlyProGlyCys-OH, (14). Compound130.8 g (0.96 mmol), was treated with 10 ml of HF 
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in the presence of 1 ml of anisole at 0°C for 1 h. The residue obtained after evaporation of HF was 
dissolved in 50 ml of water (pH was adjusted to  ca. 4 by the addition of solid NaHCO3) and washed 
with ether. To the aqueous layer was added 0.64 g (2 mmol) of mercury (II) acetate and the solu-
tion was kept at room temperature for 1 h. The solution was bubbled with H2S and filtered. The 
filtrate was diluted to 500 ml, bubbled with oxygen for 18 h in the presence of 10-6M copper (II) 
sulfate. The solution, after concentration to ca. 50 ml and ajdsted to pH 4 with formic acid, was 
applied on a column of BioRad AG5OW X-2 column and chromatography was carried out under 
the conditions of Schroeder9). Yield, 0.15 g (32%). Amino acid analysis: (1) Direct hydrolysis of 
14 gave the value, Gly :Pro-Cys2=3.0 :1.15:0.9. (2) Hydrolysis after reduction of the disulfide bond 
and pyridylethylation of the resulting thiols with 4-vinylpyridine gave GIy:Pro-Cys=3.0:1.1:1.6. 
NMR: 1.7-2.2 (4H: (Pro)CR, r-4H), 2.9-3.5 (4H: 2 (Cys) C /3-2H) , 3.5-4.1 (8H: 3(Gly)Ca-2H, 
(Pro)CS-21-1), 4.03 (t, 11-1: (Pro)Ca-H), 4.2 (1H: (Cys)Ca-H), 4.3 (1H: (Cys)Ca-H), 7.66 (d, 11-1: 
(Cys6)NH), 7.92 (t, 1H: (Gly)NH), 8.54 (t, 111: (Gly)NH), 9.12 (11-1: (Gly)NH); ammonium pro-
tons appeared as a very broad signal ranging from 3 to 4.5 ppm. 
Boc-GlyGlyCys(Acm)-OBzl, (15). HC1•H-Cys(Acm)-OBz1, 6.2 g (0.0195 mol), which was neutralized 
with 3.83 ml of DIEA, and Boc-GlyGly-OH (4.64 g, 0.02 mol) in 40 ml of DMF were coupled with 
DCC (4.33 g, 1.05 eq.)-HOBT (3.25 g, 1.2 eq.). Temperature of the reaction was kept at about 
-13°C for initial 2 h, then at 2-3°C overnight, and finally at room temperature for I day. Com-
pound 15 was recrystallized from ethyl acetate-ether. Yield, 7.7 g (80%) ; m.p. 110°C. Found: C, 
53.14; H, 6.39; N, 11.20%. Calcd for C22H3207N4S: C, 53.22; H, 6.50; N, 11.29%. TLC: Rf (I), 
0.49. 
Boc-ProGlyGlyCys(Acm)-OBzl, (16). Compound 15, 7.0 g, in a mixture of 50 ml of dichloromethane 
and 3 ml of anisole was treated with 6 ml of TFA at room temperature for 30 min. The mixture 
was concentrated and redissolved in 20 ml of ethyl acetate. To the solution was added 20 ml of HC1-
saturated ethyl acetate and the mixture was kept at room temperature for 30 min. Evaporation of 
the solvent and addition of ether afforded 5.6 g (91%) of HC1•H-GlyGlyCys (Acm)-OBzl. A mixture 
of this hydrochloride (4.35 g, 0.01 mol), Boc-Pro-OSu (3.11 g, 0.01 mol), and DIEA (2.0 ml, 1.15 eq.) 
was stirred in 30 ml of DMF at room temperature overnight. Since TLC showed the presence of 
the starting materials, 0.5 ml of DIEA was added to the reaction mixture and the reaction was con-
tinued for 24 h. After evaporation of the solvent, the residue taken in ethyl acetate was washed with 
acid and alkali, then chromatographed on Si02. Elution with chloroform-methanol (95:5) afforded 
2.8 g of 16 (47%). TLC: Rf(II) 0.63. 
Boc-GlyProGlyGlyCys(Acm)-OBzl, (17). Compound 16, 2.8 g, was dissolved in 40 ml of ethyl acetate 
and mixed with 20 ml of HCI-saturated ethyl acetate. The solution was kept at room temperature 
for 1 h and concentrated to a small volume. Addition of dry ether afforded HC1.H-ProGlyGly-
Cys(Acm)-OBz1 with quantitative yield (2.5 g). This hydrochloride (2.5 g, 4.69 mmol) was mixed 
with Boc-Gly-OSu (1.275 g, 4.69 mmol) and DIEA (1.0 ml, 1.2 eq.) in DMF (15 ml) under ice-cooling. 
The mixture was stirred at room temperature for 24 h and worked up as described above. The crude 
material was chromatographed on Si02, elution with 4% methanol in chloroform afforded 17, which 
was recrystallized from ethyl acetate, m.p. 115-117°C. Yield, 1.51 g (50%). Found: C, 53.46; H, 
6.41; N, 13.01%. Calcd for C29H4209N6S: C, 53.52; H, 6.51; N, 12.92%. TLC: Rf(I), 0.23. NMR: 
1.37 (s, 91-1: Boc), 1.83 (s, 3H: Ac), 1.85-2.0 (4H: (Pro)CQ, r-41-1), 2.87 (1H: (Cys)Cf-H), 3.00 (1H: 
(Cys)Cj-H), 3.42-3.53 (2H: (Pro)C8-2H), 3.70 (d, 211: (Gly) Ca-2H), 3.72-3.85 (4H: 2(Gly) Ca-
2H), 4.22 (t, 21-1: (Acm)CH2), 4.28 (1H: (Pro)Ca-H), 4.58 (1H: (Cys)Ca-H), 5.14 (s, 2H: (Bzl) 
CH2), 6.74 (t, 11-1: (Gly,)NH), 7.37 (5H: Ph), 7.98 (t, 11-1: (Gly)NH), 8.25 (t, 1H: (Gly)NH), 8.44 
(d, 1H: (Cys)NH), 8.53 (t, 11-1: (Acm)NH). 
Boc-Cys(Acm)GlyProGlyGlyCys(Acm)-OBzl, (18). Compound 17, 1.35 g, was dissolved in 20 ml of hot 
ethyl acetate. The solution was cooled to room temperature and was added 20 ml of HC1-saturated 
ethyl acetate. After 2 h at room temperature, the precipitate was washed out with dry ether. Yield 
of HC1•11-GlyProGlyGlyCys(Acm)-OBz1 was 1.22 g (quantitative). This hydrochloride (1.22 g, 2.08 
mmol) dissolved in 10 ml of DMF was neutralized with 0.45 ml (1.2 eq.) of DIEA and reacted with 
0.81 g of Boc-Cys(Acm)-OSu at room temperature for 24 h. After working up the reaction mixture, 
the crude material was dissolved in 3 ml of chloroform and chromatographed on Si02. Elution was 
carried out with CHC13-MeOH (92.5:7.5, v/v). Yield, 1.1 g (64%). TLC: Rf(II), 0.32; (III), 
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  0.54. Found: C, 50.43; H, 6.37; N, 13.41%. Calcd for C35H52011N5S2.1/2 H2O: C, 50.40; H, 
  6.41; N, 13.44%. NMR: 1.37 (s, 911: Boc), 1.84 (s, 3H: Ac), 1.85 (s, 311: Ac), 1.75-2.1 (4H: (Pro)- 
  Cfl, r-H), 2.6-2.7 (1H: (Cys)C,B-H), 2.83-3.03 (3H: (Cys)C,-3H), 3.4-4.05 (8H), 4.123-4.33 (6H), 
  4.55-4.62 (111: (Cys)Ca-H), 5.14 (s, 2H: (Bzl)CH2), 7.01 (d, 111: (Cysl)NH), 7.83, 8.01, and 8.19 
  (three t, 1H each: 3(Gly)NH), 8.41 (d, 111: (Cys6)NH), 8.50 (t, 1H: (Acm)NH), 8.51 (t, 113: (Acm)-
  NH). 
S------------S 
Boc-CysGlyProGlyGlyCys-OBzl, (19). The method of Ref. 10-12 was slightly modified. A solution 
  of S-protected hexapeptide 18 (1.0 g, 1.2 mmol) in a mixture of methanol (200 ml) and water (50 
  ml) was added dropwise to a stirred iodine solution (1.22 g, 4.8 mmol, in 200 ml of methanol and 
  50 ml of water). After the addition of the peptide solution was finished, the stirring was continued 
  for 1 h. Excess iodine was reduced by the addition of 350 ml of 0.02 M sodium thiosulfate. The 
  resultant solution was passed through a column of Amaberlite MB-1 (250 ml, washed before use suc-
  cessively with 400 ml of water and 500 ml of methanol-water (4:1, v/v)) and then evaporated to give 
  crystals of 19. Yield, 0.59 g (89%). The compound was recrystallized from DMF-ethanol; m.p. 
  240-241°C (dec.). Found: C, 49.64; H, 6.01; N, 11.72%. Calcd for C29H4009N6S2H2O: C, 49.84; 
  H, 6.06; N, 12.03%. NMR: 1.36 (s, 911: Boc, a satellite peak appeared at 1.38 ppm with an in-
  tensity 15.4% of 1.36 ppm peak), 1.7-1.8 (111: (Pro) Cr-H), 1.83-1.97 (2H: (Pro) Cfl, r-211), 2.13-
  2.22 (1H: (Pro)C/3-H), 2.77-2.82 (111: (Cys)Cf-H), 2.92-3.02 (211: (Cys)Cfl-2H), 3.13-3.18 (1H: 
(Cys)Cf-H), 3.46-3.67 (4H: (Gly) Ca-2H),; (Pro)C3-2H), 3.83-3.96 (2H: (Gly) Ca-2H), 4.1-4.14 
(111: (Pro)Ca-H), 4.21-4.29 (1H: (Gly)Ca-H), 4.33-4.41 ((Gly)Ca-H), 4.37-4.46 (111: (Cys)Ca-H), 
  4.98-5.06 (1H: (Cys)Ca-H), 5.16 (q, 211: (Bzl)CH2), 7.08 (d, 111: (Cysl)NH), 7.36 (511: Ph), 7.62 
  (q, 111: NH), 7.92 (q, 1H: NH), 8.49 (m, 1H: NH), 8.79 (d, 1H: NH). 
S-------------S  
II 
  Ac-CysGlyProGlyGlyCys-OBz1, (20). Boc-hexapeptide 19, 1.1 g (1.62 mmol) was converted to HCl. 
H-CysGlyProGlyGlyCys-OBz1(-SS-) in a similar way as described for the preparation of 16. The 
  hydrochloride was dissolved in 3 ml of dry DMF and treated with 0.65 ml of triethylamine (the amount 
  was determined to make the solution basic to a wet pH-test paper) and 0.5 g (3.23 mmol) of AcOSu 
  at room temperature overnight. The crystals separated were collected by filtration, the filtrate gave 
  another crop of 20 upon concentration. Yield, 0.81 g (80%°); m.p. 249-255°C. Analytical samples 
  which were recrystallized from DMF-H20 were found to contain 0.44 mol DMF/mol of 20 from NMR 
  analysis (the value was estimated from intensities of 2.72 and 2.88 ppm peaks of DMF). Found: C, 
  49.29; H, 5.58; N, 13.88%. Calcd for C26H24O8N6S2.1/2 C3H7ON•1/2 H2O: C, 49.42; H, 5.81; N, 
  13.62%. NMR: Pro-fl-, r-protons appeared at 1.7-1.8 (1H), 1.85-2.0 (211), and 2.1-2.21 (111). 
  1.85 (s, 311: Ac), 2.84-3.0 (3H: (Cys)Ci'-H), 3.16-3.23 (111; (Cys)Cfl-H), 3.48-3.66 (411: (Gly)Ca-
  211, (Pro)C8-2H), 3.82-3.93 (211: (Gly)Ca-2H), 4.13 (1H: (Pro) Ca-H), 4.22-4.36 (211: (Gly) Ca-
  211), 4.73-4.79 (1H: (Cys)Ca-H), 4.98-5.04 (111: (Cys)Ca-H), 5.16 (s, 2H: (Bzl)CH2), 7.3-7.4 (5H: 
  Ph), 7.64 (q, 111: (Gly)NH), 8.04 (q, 1H: (Gly)NH), 8.20 (d, 111: (Cysl)NH), 8.51 (t, 111: (Gly)-
  NH), 8.79 (d, 1H: (Cys6)NH). 
S-------------S  
I I 
Ac-CysGlyProGlyGlyCys-OH, (21). Compound 20, 0.5 g, was treated with HF (5 ml)-anisole (1 ml) 
  at 0°C for 30 min. After evaporation of HF, the residue was washed with ether, dissolevd in water, 
  and lyophilized. Yield, 0.436 g. Amino acid composition: Pro:Gly:Cys2=1.00:2.95:1.00. NMR: 
  1.7-1.8 (111: (Pro) Cr-H), 1.85 (s, 3H: Ac), 1.85-1.96 (211: (Pro) CQ, r-2H), 2.13-2.21 (1H: (Pro)-
  Cfl-H), 2.83-3.0 and 3.14-3.2 (411: (Cys)Cf-H), 3.46-3.63 (4H: (Gly) Ca-2H, (Pro) C8-2H), 3.82-3.93 
(211: (Gly)Ca-2H), 4.12 (1H: (ProCa-H), 4.24-4.36 (211: (Gly)Ca-2H), 4.73-4.79 (111: (Cys)Ca-H), 
  4.81-4.87 (111: (Cys)Ca-H), 7.62 (q, 1H: (Gly)NH), 8.06 (q, 111: (Gly)NH), 8.21 (d, 111: (Cys1)-
  NH), 8.51 (t, 1H: (Gly)NH) 8.67 (d, 1H: (Cys6)NH). 
S-----------S 
H-CysGlyProGlyGlyCys-OH, (22). Peptide benzyl ester 19, 0.28 g, was treated with 1 ml of anisole 
  and 5ml of HF and worked up as similarly as in the preparation of 21. Yield of 22, 0.21 g. Amino 
  acid composition: Pro: Gly: Cys2=l.00:2.91:1.03. NMR: 1.72-1.8 (111: (Pro)C8-H), 1.85-2.0 (2H: 
(Pro)C,9,8-2H), 2.13-2.21 (111: (Pro)-Cfl-H), 2.83-3.0 (311: (Cys) Cfl-H), 3.19-3.24 (1H: (Cys)C,9- 
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H), 3.48-3.65 (4H: (Gly)Ca-2H, (Pro)  CS-2H), 3.84-3.97 (3H: Ca-H), 4.14 (t, 111: (Pro) Ca-H), 
4.18-4.26 (2H: Ca-H), 4.47-4.54 (1H: (Cys)Ca-H), 7.59 (q, 1H: (Gly)NH), 8.20 (1H: (Gly)NH), 
8.55 (d, 1H: (Cys6)NH), 8.58 (t, 1H: (Gly)NH). 
HGI.H-Cys(Acm)-NHMe, (23). Boc-Cys(acm)-OH, 11.7 g, was reacted with 5.4 ml of isobutyl chloro-
formate and 4.4 ml of N-methylmorpholine in 200 ml of tetrahydrofuran at -18°C for 5 min under 
stirring. To the solution was added 10 g of solution of methylamine in DMF (4 mmol methylamine/g 
of the solution), and after 5 min, additional 1 g of the methylamine solution. The temperature of the 
reaction mixture gradually increased to nearly 0°C during 2 hours due to the consumption of cooling 
material (ice-salt). The mixture was kept at room temperature overnight and filtered. The filtrate 
was evaporated in vacuo to afford a solid mass of BocCys(acm)NHMe which was washed with diethyl 
ether and recrystallized from ca. 30 ml of water. M.p. 129-130°C, yield, 10.7 g (88%). This Boc-
compound was dissolved in the mixture of 10 ml of dichloromethane, 3 ml of anisole, and 10 ml of 
TFA, and kept at room temperature for 1 hr. The solution was evaporated and to the residue taken 
in 50 ml of ethyl acetate was added ca. 20 ml of 3M HC1 in ethyl acetate to afford 23, which was washed 
with ether. Yield, quantitative. 
Boc-Lys(e-Z)Cys(Acm)-NHMe, (24). The compound 23, 2.75 g, was neutralized with 2.05 ml of DIEA 
in 175 ml of DMF, and reacted with 4.35 g of Boc-Lys(Z)-OH, 2.3 g of HOBT, and 2.35 g of DCC in 
5 ml of ethyl acetate at -12°C for first two hours, then at 2-5°C overnight. Compound 24 was re-
crystallized from ehtanol-ethyl acetate. M.p. 158-160°C. Anal. Found: C, 54.90; H, 7.30; N, 12.23 
%. Calcd for C26H41O7N5S: C, 55.01; H, 7.28; N, 12.34%. NMR: 1.36(Boc); 1.83(Acm); 2.55 and 
2.58 (amide Me); 1.5-2.95 (Lys protons); ca. 2.8(Cys, CQ-H); 3.8 (Lys, Ca-H); ca. 4.2 (Acm, CH2); 
ca. 4.3 (Cys, Ca-H) ; 4.96 (Z, benzyl protons) ; 6.9 (Boc-NH) ; ca. 7.1 (Lys, s-NH), 7.27 (Z, aromatic 
protons); 7.8 (methylamide, NH); 6.9-8.4 (Acm, Cys, NH). TLC: 0.6 (I). 
Boc-ProGly-OH, (25). N-Hydroxysuccinimido ester of Boc-proline, 6.24 g, in 70 ml of ethanol was 
mixed with 1.5 g of glycine and 3.36 g of NaHCO3 in 50 ml water under vigorous stirring. TLC-
analysis showed that the reaction completed within 30 min. After overnight stirring, the reaction 
mixture was evaporated to remove ethanol, and redissolved in saturated aq. NaC1, acidified with 10% 
aq. citric acid, and extracted with ethylacetate. The ethyl acetate layer was washed five times with 
saturated aq. NaC1, dried over sodium sulfate, then evaporated. The residue was recrystallized from 
ethanol-ethyl acetate-cyclohexane to give 25, m.p. 169-170° (dec.) Yield, 4.5 g (83%). Anal. 
Found: C, 53.03; H, 7.29; N, 10.23%. Calcd for C12H2OO5N2: C, 52.93; H, 7.40; N, 10.29%. TLC: 
0.47 (II). 
Boc-ProGlyGlyLys (e-Z) Cys(Acm)-NHMe, (26). Compound 24 was converted to HCl•H-Lys (Z)-
Cys(Acm)-NHMe in the similar way as described for 23 (yield, quantitative). This hydrochloride, 3.8 
g, was neutralized with 1.3 ml of DIEA in ca. 40 ml of DMF and reacted with 2.2 g of 25 and 1.65 
g of DCC, in the presence of 2.05 g of HOBT, at -10°C. After about 2 hr at -10°C, the mixture 
was stood in a cold room (2-3°C) for two days with stirring. Since TLC showed the presence of the 
starting materials, 0.25 ml of DIEA and 0.2 g or DCC were added to the mixture and the reaction 
was continued at 0°C overnight. The reaction mixture wsa worked up as described above to give 
26, which was precipitated from ethanol-ethyl acetate-ether. Yield, 3.3 g (62%). Anal. Found: C, 
55.15; H, 7.08; N, 13.48%. Calcd for C33H51O9N7S: C, 54.91; H, 7.12; N, 13.59%. NMR: 1.32 
and 1.38 (Boc, intensity ratio =9:7. A presence of these two peaks suggests the existence of cis-trans 
isomerism of prolyl peptide bond.) ; 1.83 (Ac) ; Z (4.99 for CH2; 7.31 for phenyl) ; 2.55 and 2.59 
((methylamide) CH3) ; 4.24 (d, (Acm) CH2). Other protons at 1.0-2.2 (10H), 2.7-3.1 (3H), 3.1-3.6 
(311), 3.6-3.8 (2H), 4.0-4.5 (5H), 7.2 (t, Z-NH), 7.7-7.9 (1H), 7.9-8.3 (2H), and 8.5 (t, (Acm)NH). 
TLC: 0.50 (II), the value is close to that of compound 25, but the spot of 26 develops brown color 
quickly in iodine fumes, on the other hand, 25 responds only slowly. 
Boc-Glu(r-Bzl)ProGlyLys (e-Z)Cys (Acm)-NHMe, (27). To the susepnsion of 26 (2.5 g) in dichloro-
methane (25 ml), ethyl acetate (5 ml), anisole (2.5 ml), and TFA (2 ml) were added. The clear solution 
was evaporated immediately and the residue was dissolved in 3 M HC1 in ethyl acetate. After 30 
min standing at room temperature, precipitates were filtered and washed thoroughly with ether. 
Yield, 2.4 g (quantitative). The hydrochloride was suspended in 25 ml of DMF, neutralized with 
0.45 g of DIEA, and reacted with Boc-Glu (r-Bzl)-OH (2.22 g, 1.05 eq.) and DCC (0.75 g, 1.05 eq.) 
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        in the presence of HOBT (0.7 g, 1.4 eq.) at ca. -10°C for 1 hr. The reaction was continued over-
        night at 2-3°C and the mixture was worked up as usual. The compound 27 was precipitated from 
       ethanol-ether. Yield, 2.1 g (65%). Anal. Found: C, 56.74; H, 6.71; N, 11.51%. Calcd for C45-
       H64012N8S•1/2H20: C, 56.88; H, 6.90; N, 11.80%. 
Boc-Cys(Acm)Glu (r-Bzl) ProGlyLys (e-Z)Cys (Acm)-NHMe, (28). The Boc group of the compound 27 
        was removed by the treatment with a combination of TFA and HC1/ ethyl acetate as in the prepara-
       tion of 23. The compound, HCl•H-Glu(Bzl)ProGlyLys(Z)Cys(Acm)-NHMe (1.44 g, 1.64 mmol) was 
       neutralized with DIEA (0.60 ml, 1.05 eq.) and coupled to Boc-Cys(Acm)-OH (1.01 g, 1.05 eq.) with 
       DCC (0.7I g, 1.05 eq.)-HOBT (0.67 g, 1.5 eq.) in 25 ml of DMF. The coupling reaction was car-
        ried out at first at -15°C for about two hours, then at about 2°C for 20 hr, and for further 12 hr after 
        additional introduction of 0.05 ml of DIEA. The solvent was removed under reduced pressure and 
        the residue was dissolved in ethyl acetate-n-BuOH (1:1, v/v) and washed with acid and alkali as 
        described previously. As the product showed a minor ninhydrin-positive spot on TLC at Rf=0.33 
       in addition to a main spot at Rf=0.41 (solvent IV), silica gel chromatography (Merck, Lobar column) 
       with chloroform-methanol (100:7, v/v) was applied to obtain a pure 28. Yield, 1.4 g (77%). Anal. 
       Found: C, 54.34; H, 6.54; N, 12.38%. Calcd for C31H74014N1oS2.1/2H20: C, 54.48; H, 6.72; N, 
       12.46%. NMR: 1.1-2.2 (12H, except for Boc and Ac: (Pro) C/3, r-4H), (Glu) C19-2H, (Lys)Cf, r, 6-
      6H), 1.34 (Boc); 1.83 (6H: 2Ac); 2.55 and 2.60 (3H: (methylamide)CH3); 4.98 (2H: (Z)CH2); 5.07 
       (2H: (Bzl)CH2); 6.99 (d, 11-1: (Boc)-NH); 7.31 (phenyl protons of Z); 7.32 (phenyl protons of Bzl); 
       8.48 (t, 213: 2(Acm)-NH). 
       Ac-Cys(Acm)Glu (r-Bzl) ProGlyLys (e-Z)Cys (Acm)-NHMe, (29). The compound 28, 1.0 g, was dissolved 
       in a mixture of dichloromethane (5 ml), anisole (3 ml), and TFA (4 mI), and kept at room tempera-
        ture for 1 hr. The residue obtained after evaporation of volatile materials was redissolved in 50 ml 
       of ethyl acetate and was added 20 ml of HC1-saturated ethyl acetate. The hydrochloride (0.91 g) 
       was dissolved in 4 ml of DMF and neutralized with triethylamine until pH 8 on a wet indicator paper. 
        The solution was mixed with 0.25 g of AcOSu and 0.25 ml of triethylamine and stood at room tem-
        perature for 1 day. Evaporation of DMF gave the residue which was dissolved in 1-butanol and washed 
        with water, the organic phase was concentrated in vacuo. The residue was redissolved in 1-butanol 
        and the insoluble inorganic substances were removed by filtration. Addition of ether to the residue 
        obtained by evaporation of the solvent gave a crude product which was dissolved in a mixture of chrolo-
       form (8 ml), AcOH (1 ml), and methanol (0.5 ml) and chromatographed on Si02 (Merck, Lichroprep, 
       25-40 pm, 30 x 400 mm) with chloroform-methanol (95:5, 1.5 I, then 90:10, 1.5 I). The fraction 
        containing 29 were collected and evaporated. Yield, 0.563 g (58%). Anal. Found: C, 53.52; H, 
       6.34; N, 12.94%. Calcd for C46H68013N10S2•H2O: C, 53.61; H, 6.56; N, 13.03%. TLC: Rf(II), 
       0.26; (IV), 0.35. NMR: 1.2-1.3 (2H), 1.35-1.4 (2H), 1.5-1.55 (1H), 1.6-1.7 (1H), 1.75-1.9 (4H, 
       except for Ac), 1.84 (s, 9H: 3Ac), 1.95-2.05 (2H), 2.4-2.5 (2H), 2.58 (d, 3H: (methylamide)CH3), 
       2.6-2.67 (q, 111), 2.7-2.77 (q, 1H), 2.82-2.87 (lq, 1H), 2.87-2.93 (q, 113), 2.93-3.1 (411), 3.5-3.6 
(213), 3.71 (t, 113), 4.13-4.2 (1H), 4.21 (d, 4H: 2(Acm)CH2), 4.23-4.3 (2H), 4.31-4.38 (1H), 4.4-
       4.52 (1H: (Cys)Ca-H), 4.52-4.58 (1H: (Cys)Ca-H), 5.00 (s, 2H: (Z)CH2), 5.099 and 5.091 (two 
       singlets, nearly equal intensities, total 2H: (Bzl)CH2. These two peaks may reflect the presence of 
       a locked benzyl group or an isomerism about a prolyl peptide bond), 7.20 (t, 1H: (Lys) Cs-NH), 
      7.32 (IOH: 2Ph), 7.76 (q, 111: (methylamide)NH), 7.84 (d, 113), 8.06 (d, IH), 8.12 (t, 211: 2(Acm) 
       NH), 8.19 (t, 1H: (Gly)NH), 8.52 (two doublets, 2H). 
S ---------------------------S 
Ac-CysGlu (r-Bzl) ProGlyLys (e-Z) Cys-NMHe, (30). The hexapeptide 29 (0.4 g, 0.379 mmol) was dis-
       solved in 125 ml of McOH-H20 (4:1, v/v) and the oxidative deprotection of S-Acm groups were 
       achieved with 0.385 g of iodine in a similar way as described for the preparation of 19. Yield, 0.29 
      g (85%). 
S-------------S 
       Ac-CysGluProGlyLysCys-NHMe, (31). Protected hexapeptide disulfide 30, 0.25 g, was treated with 
       5 ml of HF in the presence of 1 mI of anisole at 0°C for 1 h. The yield of 31 was 0.188 g (97%). 
       Amino acid composition: Glu:Pro:Gly:Cys2:Lys=1.14:1.06:1.00:1.00:0.99. NMR: 1.15-1.35 (2H), 
       1.45-1.7 (413), 1.75-1.95 (413, except for Ac), 1.85 (s, 3H: Ac), 2.0-2.1 (1H), 2.1-2.2 (313), 2.60 (d, 
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3H:  (methylamide)CH3), 2.62-2.8 (2H), 2.82-3.13 (four quasiquartets, 4H: 2 (Cys)Cjl-2H), 3.4-3.5 
(1H), 3.57-3.62 (1H), 3.78-3.83 (1H), 3.9-3.98 (1H), 4.12 (t, 111), 4.29-4.35 (1H), 4.38-4.43 (1H), 
4.5-4.56 (111), 4.64-4.7 (1H), 7.72 (d, 1H), 7.93 (q, 1H: (methylamide)NH), 7.97 (d, 1H), 8.19 (d, 
111: (Cys1)NH), 8.43-8.46 (1H), 8.89 (t, 1H: (Gly)NH). Protons of e-ammonio group of Lys were 
observed as a very broad signal ranging from 3.5 to 4.8 ppm. 
Boc-Glu(r-Bz1)Cys(Acm)-NHMe, (32). 23, 3.02 g (0.013 mol), was dissolved in 150 ml of DMF and 
neutralized with 2.35 ml (0.0135 mol) of DIEA at 0°C. Boc-Glu (r-Bzl)-OH (4.55 g, 0.0135 mol), 
and HOBT (2.8 g, 0.021 mol) were added and 2.78 g (0.135 mol) of DCC in 10 ml of DMF was in-
troduced into the solution at -10°C. The reaction mixture was kept at about -10°C for 1 h, at 
2-3°C overnight, and worked up as usual. Compound 32 was recrystallized from ethanol-ether; m.p. 
138-140°C. Yield, 4.1 g (62%). TLC: Rf(I), 0.54. Found: C, 55.24; H, 6.85; N, 10.73%. Calcd 
for C24H36O7SN4: C, 54.95; H, 6.92; N, 10.68%. NMR: 1.39 (s, 9H: Boc), 1.85 (s, 3H: Ac), 1.9 
(2H: (Glu)C/i-2H), 2.4 (211: (Glu) Cr-2H), 2.58 (d, 3H: (methylamide) CH3), 2.8 (2H: (Cys) Cg-
2H), 4.0 (1H: (Glu)Ca-H), 4.21 (d, 2H: (Acm)CH2), 4.4 (111: (Cys)Ca-H), 5.11 (s, 2H: (Bz1)CH2), 
7.0 (d, 1H: (Glu)NH), 7.38 (5H: Ph), 7.8 (1H: (methylamide)NH), 8.0 (d, 111: (Cys)NH), 8.4 (t, 
111: (Acm)NH). 
Boc-ProGlyGlu(r-Bzl)Cys(Acm)-NHMe, (33). Compound 32 was treated with HC1/ethyl acetate 
in a similar way as descrived for 2. Yield of HCl•Glu (Bzl)Cys(Acm)-NHMe was 3.5 g (quan-
titative). This hydrochloride (3.5 g, 7.6 mmol) dissolved in DMF (30 ml) was neutralized with 1.35 ml 
of DIEA and coupled to 2.1 g (7.7 mmol) of 25 with DCC (1.6 g, 7.6 mmol) and HOBT (1.6 g, 11.8 
mmol) at -10°C for first 1 h, then at 2-3°C for 36 h. The product obtained after a usual workup pro-
cedure was recrystallized from ethanol-ether; m.p. 187-191°C. TLC: Rf(I), 0.32. Found: C, 54.66; 
H, 6.75; N, 12.42%. Calcd for C31H46O9N6S: C, 54.85; H, 6.83; N, 12.38%. NMR (distinct signals) : 
1.35 (s, 9H: Boc), 1.85 (s, 3H: Ac), 2.4 (211: (Glu) Cr-2H), 2.59 (d, 3H: (methylamide)CH3), 4.2 
(d, 2H: (Acm)CH2), 5.10 (s, 2H: (Bzl)CH2), 7.38 (5H: PH), 7.78 (q, 111: (methylamide)NH), 8.1 
(3H), 8.48 (t, 111: (Acm)NH). 
Boc-Lys (e-Z) ProGlyGlu (r-Bz1)Cys (Acm)-NHMe, (34). Compound 33, 3.0 g (4.42 mmol), was con-
verted to HCI•H-ProGlyGlu(Bz1)Cys(Acm)-NHMe as described in the preaparation of 23. Yield, 
quantitative. This hydrochloride, 2.75 g (4.42 mmol), was neutralized with 0.72 ml of DIEA in 
30 ml DMF at 0°C and mixed with 1.28 g (4.42 mmol) of Boc-Lys (e-Z)-OH and 0.9 g (6.63 mmol) 
of HOBT. The reaction with 0.92 g of DCC in 5 ml of DMF was carried out at -10°C for 1 h, and 
at 2-3°C afterwards. After 12 h from the start of the reaction, 0.5 ml of DIEA was added to the reac-
tion mixture and the reaction was continued for 24 h. The filtrate was worked up in the usual manner 
to afford 2.8 g (66%) of 34 (the product was precipitated from ethyl acetate solution by the addition 
of ether); m.p. 98-100°C. TLC: Rf (II), 0.58. Found: C, 57.45; H, 6.79; N, 11.81%. Calcd for 
C46H64O12N8S: C, 57.43; H, 6.86; N, 11.91%. NMR (distinct peaks): 1.34 (s, 911: Boc), 1.83 (s, 3H: 
Ac), 2.32-2.39 (2H: (Glu)Cr-2H), 2.47 (d, 3H: (methylamide)CH3), 4.21 (d, 2H: (Acm) CH2), 4.95 
(s, 2H: (Z)CH2), 5.02 (s, 2H: (Bzl)CH2), 6.81 (d, 1H: (Lys)NH), 7.20 (1H: (Lys)Ca-NH), 7.3 (5H: 
PH), 7.32 (5H: Ph), 7.7-8.0 (2H), 8.05-8.3 (2H), 8.48 (t, 1H: (Acm)NH). 
Boc-Cys (Acm)Lys (e-Z)ProGlyGlu (r-Bzl)Cys (Acm)-NHMe, (35). To a solution of compound 34, 2.42 g 
(2.57 mmol) in 50 ml of ethylacetate, was added 25 ml of HC1-saturated ethyl acetate. Solid mass of 
HC1•H-Lys(Z)ProGlyGlu(Bzl)Cys(Acm)-NHMe was washed out with ether, dried, dissolved in 25 ml 
of DMF, and neutralized with 0.45 ml (2.58 mmol) of DIEA. DCC reaction (Boc-Cys(Acm)-OH, 
0.79 g, 1.05 eq.; HOBT, 0.52 g, 1.5 eq.; DCC, 0.56 g, 1.05 eq.) was carried out at -13°C for first 1 h, 
then at 2-3°C afterwards. After 24 h, 0.15 g of Boc-Cys(Acm)-OH, 0.15 ml of DIEA, and 0.11 g of 
DCC were added to the reaction mixture and the reaction was continued for further 48 h. The residue 
obtained after evaporation of the solvent was taken in 1-butanol and washed as described above. The 
crude hexapeptide was chromatographed on SiO2, which was eluted with CHC13-MeOH (10: 1, v/v). 
Yield, 1.28 g (43%); m.p. 148-150°C. TLC: Rf (IV), 0.60. Found: C, 54.51; H, 6.68; N, 12.38%. 
Calcd for C61H74O14N10S2.1/2H2O: C, 54.48; H, 6. 72; N, 12.46. NMR: 1.38 (s, 911: Boc), 1.2-1.55 
(611), 1.6-1.7 (111), 1.8-1.86 (211), 1.9-2.05 (311), 2.41 (t, 211: (Glu)Cr-211), 2.58 (d, 311: (methyl-
amide)C113), 2.6-2.95 (4H: 2(Cys)Cfl-H), 2.97 (211: (Lys)Ce-2H), 3.5-3.57 (1H), 3.6-3.66 (111), 
3.69-3.75 (211), 4.1-4.2 (211), 4.22 (d, 211: (Gly)Ca-H), 4.25-4.4 (411), 4.44------4.45 (1H), 5.00 (s, 211: 
(Bzl)CH2), 5.09 (s, 211: (Bzl)CH2), 6.96 (d, 1H: (Cys1)NH), 7.21 (t, 1H), 7.77 (q, 1H), 7.83 (d, 1H), 
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7.92 (d, 1H), 8.17 (d and t, 2H), 8.51 (two t, 2H: (Acm)NH). 
Ac-Cys (Acm) Lys (6-Z)ProGlyGlu (r-Bzl)Cys (Acm)-NHMe, (36). HC1•H-Cys (Acm) Lys (Z) ProGly-
Glu(Bzl)Cys(Acm)-NHMe, 0.79g (0.756 mmol), which was derived from 0.96 g of 35, was dissolved in 
5 ml ofDMF-0.21 ml triethylamine (2 eq.) and reacted with 0.18 g (1.5 eq.) of AcOSu at 0°C for 2 days. 
The mixture was concentrated to a smaller volume and water was added to separate 0.83 g (91%) of 
36; m.p. 183-185°C. Found: C, 54.04; H, 6.43; N, 13.01%. Calcd for 'C48H65013N10S2.1/2 H O: 
C, 54.07; H, 6.52; N, 13.14%. NMR (distinct peaks): 1.84 (s, 911: 3Ac), 2.58 (d, 3H: (methylamide)-
CH3), 4.98 (s, 2H: (Z)CH2), 5.06 (s, 211: (Bz1)CH2), 7.2 (2H: 2NH), 7.3 (5H: PH), 7.32 (5H: Ph), 
7.78 (q, 1H: (methylamide )NH), 7.95 (1H), 8.0-8.3 (3H), 8.48 (t, 2H: 2(Acm)NH). 
S---------------------------S 
Ii A
c-CysLys(e-Z) ProGlyGlu(r-Bzl)Cys-NHMe, (37). A solution of 0.5 g (0.48 mmol) of 36 in 150 ml 
of McOH-H20 (4: 1) was treated with 0.48 g of iodine in a similar way as described in the preparation 
of 19. Yield of 37, 0.4 g (93%). TLC: Rf (III), 0.31. Found: C, 54.25; H, 5.99; N, 12.12%. 
Calcd for C42H56011N8S2• H20: C, 54.18; H, 6.28; N, 12,04%. NMR: 1.28-1.40 (4H), 1.43-1.52 (111), 
1.57-1.67 (1H), 1.74-1.91 (3H, except for Ac), 1.85 (31-1: Ac), 2.0-2.14 (3H), 2.22-2.42 (2H: (Glu)-
Cr-2H), 2.61 (d, 3H: (methylamide)CH3), 2.82-2.92 (2H: (Cys) C19-2H), 2.93-2.98 (2H: (Lys) Ce-
211), 3.02-3.08 (1H: (Cys)Cf-H), 3.10-3.16 (111: (Cys)C/9-H), 3.39-3.51 (2H: (Pro)C8-2H), 3.75-
3.80 (1H: (Glu) or (Lys)Ca-H, coupled to 7.81 ppm signal), 3.97-4.03 (1H: (Glu) or (Lys)Ca-H, 
coupled to 8.09 ppm signal), 4.11 (t, 1H: (Pro)Ca-H), 4.4-4.49 (2H: (Gly)Ca-2H), 4.63-4.68 (111: 
(Cys)Ca-H), 4.72-4.77 (1H: (Cys)Ca-H), 4.99 (s, 2H: (Z)CH2), 5.06 (d, 211: (Bz1)CH2i see a com-
ment for 29), 7.19 (t, 1H: (Lys)e-NH), 7.27-7.37 (10H: 2Ph), 7.81 (d, 1H: (Glu) or (Lys) NH), 8.03 
(q, 1H: (methylamide)NH), 8.09 (d, 1H: (Glu) or (Lys)NH), 8.21 (d, 1H: (Cys) NH), 8.26 (d, 1H: 
(Cys)NH), 8.70 (q, 111: (Gly)NH). 
S------------S 
Ac-CysLysProGyGluCys-NHMe, (38). Compound 37, 0.4 g, was treated with 5 ml HF and 1 ml 
of anisole at 0°C for 30 min and the product 38 was lyophilized from water. Yield, 0.32 g. Amino 
acid analysis: Pro: Glu: Gly: Lys: Cys2=1.00: 1.08: 0.98: 1.00: 0.91. NMR: 1.3-1.7 (611), 1.75-1.97 
(4H, except Ac), 1.85 (s, 311: Ac), 2.0-2.2 (411), 2.59 (d,3H: (methylamide)CH3), 2.74 (211: (Lys)- 
Ce-2H), 2.88-2.93 (11-1: (Cys)Cfi-H), 3.01-3.08 (111: (Cys)Cfl-H), 3.10-3.21 (2H: (Cys)Cfl-2H), 
3.38-3.44 (1H: (Pro)C8-H), 3.46-3.52 (111: (Pro)CS-H), 3.74-3.80 (111: (Lys)Ca-H), 4.00-4.08 (1H: 
(Glu)Ca-H), 4.12 (t, 1H: (Pro)Ca-H), 4.31-4.37 (1H: (Cys)Ca-H), 4.38-4.44 (2H: (Gly)Ca-2H), 
4.56-4.61 (1H: (Cys)Ca-H), 7.87 (d, 1H: (Glu) or (Lys)NH), 7.89 (d, 1H: (Glu) or (Lys)NH), 8.02 
(q, 1H: (methylamide)NH), 8.10 (d, 1H: (Cysl)NH), 8.75 (d, 111: (Cys6)NH), 8.78 (q, 1H: (Gly)NH). 
Lys-e-ammonium protons appeared as a broad signal ranging from 4.0 to 4.7 ppm. 
Boc-ValCys(Acm)-NHMe, (39). Compound 23, 5 g (0.0205 mol), was suspended in 200 ml of DMF 
and warmed. When most of the hydrochloride was dissolved, the mixture was cooled, neutralized with 
3.65 ml (0.021 mol) of DIEA, and added 4.56 g (0.021 mol) of Boc-Val-OH and 4.3 g (1.5 eq.) of 
HOBT. Addition of DCC (4.33 g, 0.021 mol) was carried out at -10°C, the mixture was stood at 
2-3°C for 2 days, filtered, and the solvent was evaporated. The residue taken in wet 1-butanol was 
washed with aq. citric acid and aq. hydrogen carbonate several times. These aqueous washes were 
extracted with ethyl acetate which was combined with the 1-butanol layer. The combined organic 
phase was dried and evaporated to afford 5.5 g (66%) of 39; m.p. 159-160°C. Found: C, 50.33; 
H, 7.98; N, 13.91%. Calcd for C17H3205N4S: C, 50.47; H, 7.97; N, 13.85%. 
Boc-ProGlyValCys(Acm)-NHMe, (40). HCI•H-ValCys(Acm)-NHMe, 3.8 g (0.011 mol), which was obtain-
ed from 4.5 g (0.011 mol) of 39 by the method described for 23 was dissolved in 150 ml of DMF, neutralized 
with 1.96 ml (0.011 mol) of DIEA, and reacted with 3.03 g (0.011 mol) of 25, 2,28 g of DCC, and 2.26 g 
(1.5 eq.) of HOBT. DCC reaction was carried out at first at -10°C for 2 h, then at 2-3°C for 24 h, 
and the mixture was filtered. The filtrate was concentrated, the residue taken in 1-butanol was worked 
up as described above. Yield, 5.2 g (84%); m.p. 222-223°C (EtOH-Et20). Found: C, 51.03; H, 
7.52; N, 14.88%. Calcd for C24H4207N6S•1/4 H2O: C, 51.18; H, 7.61; N, 14.92%. NMR: 0.9 
(6H: (Val)Cr-6H), 1.34 (9H: Boc), 1.83 (s, 3H: Ac), 1.8 (413: (Pro)C,, r-4H), 2.0 (1H: (Val)Cfi-H), 
2.57 (d, 311: (methylamide)CH3), 2.8 (211: (Cys)Cj-2H), 3.3 (2H: (Pro)C8-2H), 3.7 (2H: (Gly)Ca-
                           ( 502)
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 211), 3.9-4.5 (3H except (Acm)CH2), 4.19 (d, 2H: (Acm)CH2), 7.7 (2H), 8.2 (211: (Gly)NH, (methyl-
amide) NH), 8.49 (t, 1H: (Acm)NH). 
HCI H-ProGlyValCys(Acm)-NHMe, (41). Compound 40, 4 g (7.2 mmol), was deblocked by a similar 
method described for 23. Yield of 41, 3.2 g; m.p. 225-226°C (recrystallized from DMF). Found: 
C, 45.71; H, 7.07; N, 17.00%. Calcd for C19H35O5N6SC1: C, 46.09; H, 7.13; N, 16.98%. 
Boc-ValProGlyValCys(Acm)-NHMe, (42). To a suspension of 3.0 g (6.1 mmol) of 41 in 100 ml of DMF 
was added 1.14 ml (6.5 mmol) of DIEA, Boc-Val-OH (1.4 g, 6.4 mmol), HOBT (1.3 g, 9.6 mmol), 
and DCC (1.33 g, 6.4 mmol, addition at -10°C). After the mixture was stood at 2-3°C for 48 h, 
0.28 g of Boc-Val-OH and 0.27 g of DCC were added, and the whole mixture was worked up after 24 h 
at 0°C as described in the preparation of 15. Yield of powders of 41 from ethanol-ethyl acetate was 
3.29 g (82%). TLC: Rf (I), 0.34; (II), 0.56. Found: C, 52.50; H, 7.58; N, 14.45%. Calcd for 
C29H51O8N7S•1/4 H2O: C, 52.59; H, 7.84; N, 14.81%. NMR; 0.8-0.9 (12H: 2 (Val)Cr-6H), 1.55 
(s, 9H: Boc), 1.6-2.2 (611 except for Ac: (Pro)Cg, r-4H, 2(Val)Cf-H), 1.82 (311: Ac), 2.57 (d, 3H: 
(methylamide) CH3), 2.7-2.9 (211: (Cys)C/9-2H), 3.2-3.4 (211: (Pro)C8-2H), 3.6-4.5 (4H, except for 
(Acm)CH2: Ca-protons other than Gly), 4.19 (d, 2H: (Acm)CH2), 6.79 (d, 111: (Vall)NH), 7.6-7.9 
(2H), 8.0-8.3 (2H), 8.49 (t, 1H: (Acm)NH). 
Boc-Cys(Acm)ValProGlyValCys(Acm)-NHMe, (43). HCI•H-ValProGlyValCys(Acm)-NHMe, which was 
prepared from 2.9 g (4.4 mmol) of 42 in a similar manner as for 23, was dissolved in 20 ml of 
DMF and neutralized with 0.80 ml (1.05 eq.) of DIEA. Boc-Cys(Acm)-OH (1.35 g, 1.05 eq.) was 
coupled to this peptide with DCC .(0.95 g, 1.05 eq.)-HOBT (0.89 g, 1.5 eq.) at first at about -10°C 
for 2 h then at 0°C for 48 h with intermittent addition of DCC and Boc-Cys(Acm)-OH (total 95 mg 
and 135 mg, respectively). The residue after concentration of the filtrate was dissolved in 1-butanol 
and washed successively with aq. citric acid and 3% hydrogen carbonate-0.01 M NaOH. The crude 
product was chromatographed on SiO2 with CHC13-MeOH (100:7). Yield, 1.5 g (41%). Found: 
C, 49.56; H, 7.15; N, 14.84%. Calcd for C35H6501oN9S2•H2O: C, 49.45; H, 7.47; N, 14.83%. NMR: 
0.8-0.92 (12H: 2(Val)Cr-H), 1.35 (9H: Boc), 1.77-1.88 (211: (Pro) Cg-2H), 1.9-2.1 (4H: (Pro)-
Cr-2H, 2(Val)Cg-H), 2.59 (d, 311: (methylamide)CH3), 2.6-2.91 (411: 2 (Cys)C/1-2H), 3.55-3.61 
(1H), 3.65-3.81 (311), 4.10-4.23 (5H), 4.26-4.40 (4H), 7.01 (S, IH: (Cys1)NH), 7.64 (d, 1H: (Val)-
NH), 7.69 (d, IH: (Val)NH), 7.77 (q, 111: (methylamide)NH), 8.15 (d, 1H: (Cys6)NH), 8.18 (t, 
1H: (Gly)NH), 8.50 (t, 1H: (Acm)NH), 8.51 (t, 1H: (Acm)NH). 
Ac-Cys(Acm)ValProGlyValCys(Acm)-NHMe, (44). A mixture of HC1•H-Cys(Acm)ValProGlyVal-
Cys(Acm)-NHMe, which was prepared from 1.25 g (1.1 mmol) of compound 43 in the similar way as 
described for 23, triethylamine (0.32 ml) and AcOSu (0.36 g, 2.3 mmol) in 20 ml of DMF was stirred 
at room temperature for 48 h. Evaporation of DMF afforded a residue, which was dissolved in 
ethanol. Precipitates obtained by an addition of ethyl acetate were dissolved in water (a small volume 
of McOH was added to make the solution homogeneous) and the solution was passed through a col-
umn of Amberlite MB-1. Evaporation of the solvent afforded 0.82 g (71%) of 44, which was recry-
stallized from EtOH-Et2O; m.p. 197-198°C. TLC: Rf(III), 0.54. Found: C, 48.63; H, 6.98; N, 
15.81%. Calcd for C32H55O9N9S2•H2O: C, 48.53; H, 7.26; N, 15.92%. NMR: 0.82-0.91 (12H: 
2(Val)Cr-H), 1.846 (s, 311: Ac), 1.854 (s, 311: Ac), 1.860 (s, 311: Ac), 1.77-2.1 (6H, except three 
Ac: (Pro)Cf,r-4H, 2(Val)Cg-H), 2.59 (d, 3H: (methylamide)CH3), 2.6-2.9 (4H: 2(Cys)Cf-2H), 
3.54-3.61 (111), 3.68-3.81 (3H), 4.10-4.23 (411), 4.28-4.34 (3H), 4.35-4.40 (11-1: (Cys)Ca-H), 4.51-
4.58 (111: (Cys)Ca-H), 7.65 (d, 111: (Val)NH), 7.77 (q, 111: (methylamide) NH), 7.83 (d, 111: (Val)-
NH), 8.13 (d, IH: (Cys)NH), 8.16 (d, 111: (Cys)NH), 8.19 (t, 111: (Gly)NH), 8.59 (t, 111: (Acm)- 
NH), 8.52 (t, 111: (Acm)NH). 
S--------------S 
II 
Ac-CysValProGlyValCys-NHMe, (45). A solution of Acm-peptide 44, 0.5 g (0.646 mmol), in a mix-
ture of 200 ml McOH and 50 ml H2O was treated with iodine (0.66 g, 2.6 mmol) and worked up in 
a similar way as described for 19. After treatment with Amberlite MB-1, concentration of the solu-
tion afforded 0.33 g (80%) of 45, which was recrystallized from DMF-H2O; m.p. 262-264°C. Found: 
C, 48.91; H, 6.67; N, 15.57%. Calcd for C25H43O7N7S2.1/2 H2O: C, 48.88; H, 6.94; N, 15.35%. 
Amino acid composition: Pro :Gly :Val:Cys2=1 :0.99 :1.78 :0.93. NMR: 0.76-0.95 (a pair of quartet, 
12H: 2(Val)Cr-H), 1.76-1.91 (211, except Ac: (ProCr-2H), 1.87 (s, 311: Ac), 2.0-2.2 (4H: (Pro)-
C9-211, 2(Val)C,9-H), 2.62 (d, 311: (methylamide) CH3), 2.83-3.03 (4H: 2(Cys)Cfi-2H), 3.3-3.56 
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                                         S.  TAKAHASHI 
  (2H: (Pro)CS-2H), 3.85-3.91 (1H), 4.08-4.26 (3H), 4.37-4.41 (1H), 4.63-4.69 (1H), 4.81-4.87 
(1H), 7.65 (d, 1H), 8.02 (q, 1H: (methylamide)NH), 8.05 (d, 111), 8.07 (d, 1H), 8.29 (d, 1H: (Cysl)-
  NH), 8.67 (broad, 1H). 
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